News & Events

Access to abortion care in France during the COVID-19 pandemic

26th May 2020

In France, medical abortion in the first trimester has been allowed via telemedicine, due to the current pandemic, and women are also allowed to obtain an abortion in the second trimester, beyond the current 12 weeks limit, because of the psycho-social distress that the emergency situation and an eventual illness can provoke.   

 

  1. RECOMMANDATIONS REGIONALES COVID 19 sur l’IVG (16/03/2020): rédaction par ARS DSP. Relecture par Dr Ph Faucher (Trousseau/REVHO)– Dr S Gaudu (Bicêtre/REVHO) – Dr Sophie Eyraud (REVHO) – Dr S Pozzi-Gaudin (Béclère) https://www.iledefrance.ars.sante.fr/system/files/2020-04/Covid19-IVG-03-Recommandations-ARSIDF.pdf 
  2. Arrêté du 14 avril 2020 complétant l’arrêté du 23 mars 2020 prescrivant les mesures d’organisation et de fonctionnement du système de santé nécessaires pour faire face à l’épidémie de covid-19 dans le cadre de l’état d’urgence sanitaire | Legifrance
  3. Article juridique détaillé sur Covid-19 et IVG médicamenteuse : les délais prolongés https://www.actualitesdudroit.fr/browse/civil/personnes-et-famille-patrimoine/26963/covid-19-et-ivg-medicamenteuse-les-delais-prolonges 
  4. HAS : Interruption Volontaire de Grossesse (IVG) médicamenteuse à la 8ème et à la 9ème semaine d’aménorrhée (SA) hors milieu hospitalier 
  5. Recommandations du CNGOF (COLLÈGE NATIONAL DES GYNÉCOLOGUES ET OBSTÉTRICIENS FRANÇAIS) sur les IVG et la contraception durant l’épidémie de COVID : http://www.cngof.fr/coronavirus-go-cngof 
  6. Depuis le 3 avril, l’ensemble des consultations nécessaires aux IVG médicamenteuses pourront être réalisées sous forme de téléconsultations, si la femme le souhaite et le praticien l’estime possible : https://solidarites-sante.gouv.fr/actualites/presse/communiques-de-presse/article/ivg-et-covid-19 
  7. Tribune des professionnels de santé : « IVG et Covid, protéger les droits des femmes et maintenir l’accès à l’avortement » : http://www.ivg-covid.fr 
  8. Communiqué de presse du Ministère des Solidarités et de la Santé : Pilule contraceptive, IVG : le gouvernement mobilisé pour assurer les droits sexuels et reproductifs des femmes
    https://solidarites-sante.gouv.fr/actualites/presse/communiques-de-presse/article/pilule-contraceptive-et-ivg?var_mode=calcul 

 

« Go Back

Share your Story

We are aware of the great difficulties that women who want to interrupt their pregnancy in Europe have to face. That’s why we invite you to share your experience with the project team. With your help, we will be able to improve the study and create a community useful information for all.

If you wish to share your experiences with difficulties accessing abortion care and/or abortion travel please use the form on the right.  

If you tick the box: “I consent to share my story with the research team for research purposes in the terms described on the left side”, researchers will use the story to analyse the barriers to access to safe, legal abortion that lead women to seek illegal abortion or travel to seek abortion care, and women’s experiences with that.

If you also tick the box: “I consent to publish my story in this section” we will anonymize your story and publish it in this section, with only your nickname and/or country (if provided). 

NOTE:
You may choose a nickname to avoid using your real name. We do not collect any personal data, but if you accidentally provide some personal data in your story, we will store this information in a protected file “Research, development and innovation projects with high-level personal data” at the University of Barcelona with the only purpose to anonymize your story by deleting any personal data, and then delete the original story you sent. We will only keep and eventually publish its anonymous version on this website ONLY IF you consent to your story being published by ticking the appropriate box above. Only researchers administering this website have access to its content.

The body responsible for the above file is the General Secretary of the University of Barcelona located on: Gran Via de les Corts Catalanes 585, 08007 Barcelona; email: secretaria.general@ub.edu. You have the right to access, and receive your data in a file (e.g. word, PDF) during the period of the study (5 years). You can also ask and obtain that researchers stop examining them  , and/or ask to correct or request your data to be deleted for up to six months after participating, by emailing your request to the project: bar2legab@ub.edu or to the principal investigator, Dr. Silvia De Zordo: silviadezordo@ub.edu. Please indicate your nickname in your email.

If you need information about this project, please contact us by writing to bar2legab@ub.edu
If you want to read your rights as a participant, visit our Research Ethics section

    Send us your story



    The researchers will review your story and published it (if you have agreed to it) one week after your submission. If you wish to cancel your submission, change your mind about participating, or simply ticked the wrong box when submitting your story, please write to the research team using the email address to the left.

    Europe Abortion Access Project Euroe Research Council Universitad de Barcelona

    This project has received funding from the European Reseach Council (ERC) under the European Union's Horizon 2020 research and innovation programme BAR2LEGAB-680004